{"id":46647,"date":"2022-07-27T19:02:03","date_gmt":"2022-07-27T17:02:03","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/hand-eczema-he-epidemiology-forecast-report-2022-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/"},"modified":"2022-07-27T19:02:03","modified_gmt":"2022-07-27T17:02:03","slug":"hand-eczema-he-epidemiology-forecast-report-2022-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/hand-eczema-he-epidemiology-forecast-report-2022-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/","title":{"rendered":"Hand Eczema (HE) Epidemiology Forecast Report 2022-2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Hand Eczema (HE) – Epidemiology Forecast – 2032”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThis ‘Hand Eczema (HE)- Epidemiology Forecast – 2032’ report delivers an in-depth understanding of Hand Eczema (HE) historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.\n<\/p>\n

\nHand Eczema (HE) Disease Understanding<\/strong>\n<\/p>\n

\nHand Eczema (HE), also known as hand dermatitis, is one of the most common types of eczema and one of the most prevalent skin conditions worldwide. It mainly affects the palms but can also affect other parts of the hand. The severity of HE may range from very mild to severe and the course from acute to chronic, resulting in prolonged disability.\n<\/p>\n

\nHand Eczema (HE) Epidemiology<\/strong>\n<\/p>\n

\nHand Eczema (HE) epidemiology division provides insights into the historical and incident patient pool, along with the forecasted trend for all seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The report also provides the diagnosed patient pool, trends, and assumptions.\n<\/p>\n

\nKey Findings<\/strong>\n<\/p>\n

\nThe total prevalent cases of Hand Eczema (HE) patients in the 7MM are increasing during the study period, i.e., 2019-2032.\n<\/p>\n

\nThe disease epidemiology covered in the report provides historical as well as forecasted Hand Eczema (HE) symptoms epidemiology segmented as the total Prevalent cases of Hand Eczema, gender-specific cases of Hand Eczema, severity-specific cases of Hand Eczema, subgroup-specific cases of Hand Eczema, and age-specific cases of Hand Eczema.\n<\/p>\n

\nThe report includes the prevalent cases scenario of Hand Eczema (HE) in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2019 to 2032.\n<\/p>\n

\nCountry-wise Hand Eczema (HE) Epidemiology<\/strong>\n<\/p>\n

\nThe epidemiology segment also provides Hand Eczema (HE) epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.\n<\/p>\n

\nThe prevalent cases of Hand Eczema (HE) associated in 7MM countries were around 63,300,000 in 2021.\n<\/p>\n

\nAmong the EU5 countries, Germany had the highest prevalent cases of Hand Eczema (HE), followed by the United Kingdom. On the other hand, Spain had the lowest prevalent cases with approximately 3,900,000 cases in 2021.\n<\/p>\n

\nScope of the Report<\/strong>\n<\/p>\n